Scientific excellence for over 40 years
Since 1977 Scantox has been a trusted partner for in-vivo preclinical research services for the pharmaceutical and medical device industries. Our services and expertise enable clients to progress their drug or device development based on consistent, high-quality solid data to the highest technical and scientific standards.
Science News
Get easy access to our latest news!
Why Scantox as your preferred CRO?
This enables clients to progress their development projects under one roof in a trustworthy collaborative matter based on the highest technical and scientific standards.
Questions?
Contact one of our specialists
Scantox offers a comprehensive portfolio of screening and regulatory genotoxicity products & services, along with assessment of skin sensitisation potential.
Regulatory toxicology is one of our core competences, and Scantox has for many years been a leading expert withinsafety studies using the Göttingen Minipig. We offer a full spectrum of preclinical toxicology studies, incl. GLP, and a wide species selection.
We offer formulation development and dose formulation manufactory including logistics for phase 1 and 2 clinical trials. Further, a full spectrum of bioanalysis with a comprehensive full package of LCMC/MS method development, validation
and sample analysis for both for exploratory, regulatory studies and clinical.
New Insights into Tau Structures Unite FTD Research
Could a New ALS Drug Also Treat Alzheimer’s Disease?
It’s All about Aging
Motoneuron Loss and Disturbed Autophagic Signaling in B6.SOD1-G93A Mice
Annual Report 2024 released
ACT 2024: Stay Ahead With Scantox’s Expanded Toxicology Services
Scantox Showcases Cell and Gene Therapy Capabilities at ESGCT 2024
Careers at Scantox
We are continuously looking for new talents to join our team. Check out our open positions or send us your CV and an unsolicited application.
